BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21413905)

  • 1. Water-in-oil microemulsions for effective transdermal delivery of proteins.
    Russell-Jones G; Himes R
    Expert Opin Drug Deliv; 2011 Apr; 8(4):537-46. PubMed ID: 21413905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal peptide delivery using colloidal carrier systems.
    Goebel A; Neubert RH
    Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionic liquid-in-oil microemulsion as a potential carrier of sparingly soluble drug: characterization and cytotoxicity evaluation.
    Moniruzzaman M; Tamura M; Tahara Y; Kamiya N; Goto M
    Int J Pharm; 2010 Nov; 400(1-2):243-50. PubMed ID: 20813174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of microemulsions in dermal and transdermal drug delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2008; 21(5):246-59. PubMed ID: 18562799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery.
    Lapteva M; Kalia YN
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1043-59. PubMed ID: 23600804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermal delivery of desmopressin acetate using colloidal carrier systems.
    Getie M; Wohlrab J; Neubert RH
    J Pharm Pharmacol; 2005 Apr; 57(4):423-7. PubMed ID: 15831201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsions: applications in transdermal and dermal delivery.
    Date AA; Patravale VB
    Crit Rev Ther Drug Carrier Syst; 2007; 24(6):547-96. PubMed ID: 18298390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microemulsion formulations for the transdermal delivery of testosterone.
    Hathout RM; Woodman TJ; Mansour S; Mortada ND; Geneidi AS; Guy RH
    Eur J Pharm Sci; 2010 Jun; 40(3):188-96. PubMed ID: 20304048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in protein and peptide delivery by noninvasive routes.
    Wearley LL
    Crit Rev Ther Drug Carrier Syst; 1991; 8(4):331-94. PubMed ID: 1769066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
    Chen L; Tan F; Wang J; Liu F
    Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in inflammation in the footpad of carrageenan treated mice following the topical administration of anti-TNF molecules formulated in a micro-emulsion.
    Himes R; Lee S; McMenigall K; Russell-Jones GJ
    J Control Release; 2010 Aug; 145(3):210-3. PubMed ID: 20470838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transport effect of submicron emulsions on 5-flurouracil topical application.
    Huang YB; Huang CT; Tsou HY; Fu LT; Fu YS; Tsai YH; Wu PC
    J Microencapsul; 2013; 30(5):425-31. PubMed ID: 23510368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition.
    El Maghraby GM
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):595-600. PubMed ID: 19892531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging strategies for the transdermal delivery of peptide and protein drugs.
    Schuetz YB; Naik A; Guy RH; Kalia YN
    Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug.
    Osborne DW; Ward AJ; O'Neill KJ
    J Pharm Pharmacol; 1991 Jun; 43(6):450-4. PubMed ID: 1717675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomedical applications of microemulsion through dermal and transdermal route.
    Shukla T; Upmanyu N; Agrawal M; Saraf S; Saraf S; Alexander A
    Biomed Pharmacother; 2018 Dec; 108():1477-1494. PubMed ID: 30372850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended release of lidocaine from linker-based lecithin microemulsions.
    Yuan JS; Acosta EJ
    Int J Pharm; 2009 Feb; 368(1-2):63-71. PubMed ID: 19010404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.